跳转至内容
Merck
CN

345695

四氯化钛(IV) 溶液

1.0 M in toluene

别名:

四氯化钛

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
TiCl4
化学文摘社编号:
分子量:
189.68
NACRES:
NA.55
PubChem Substance ID:
UNSPSC Code:
12352300
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI

1S/4ClH.Ti/h4*1H;/q;;;;+4/p-4

SMILES string

Cl[Ti](Cl)(Cl)Cl

InChI key

XJDNKRIXUMDJCW-UHFFFAOYSA-J

form

liquid

reaction suitability

reagent type: catalyst
core: titanium

concentration

0.95-1.10 M NaOH (titration), 1.0 M in toluene

density

0.964 g/mL at 25 °C

正在寻找类似产品? 访问 产品对比指南

General description

Titanium(IV) chloride participates in the Baylis-Hillman reaction of arylaldehydes with methyl vinyl ketone.

Application

TiCl4 can be used as a precursor for the synthesis of nanosized titaniuim dioxide.

signalword

Danger

target_organs

Central nervous system, Respiratory system

supp_hazards

存储类别

3 - Flammable liquids

flash_point_f

46.4 °F - closed cup

flash_point_c

8 °C - closed cup

Hazard Classifications

Acute Tox. 2 Inhalation - Aquatic Chronic 3 - Asp. Tox. 1 - Eye Dam. 1 - Flam. Liq. 2 - Repr. 2 - Skin Corr. 1B - STOT RE 2 Inhalation - STOT SE 3

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Precipitation of nanosized titanium dioxide from aqueous titanium (IV) chloride solutions by neutralization with MgO.
Li Y and Demopoulos GP.
Hydrometallurgy, 90(1), 26-33 (2008)
Titanium(IV) chloride and the amine-promoted baylis-hillman reaction
Shi et al.
Organic letters, 2(23), 3755-3755 (2000-11-14)
Denton, S.M. Wood, A.
Synlett, 55-55 (1999)
Charles Dylan Turner et al.
Organic letters, 14(18), 4970-4973 (2012-09-08)
The Ti(IV)-catalyzed Ugi condensation of α-amino acids with electron-rich aromatic aldehydes performs adequately even with sterically demanding α-amino carboxylate salts. The reaction occurs diastereoselectively, in some cases with virtually complete diastereoselectivity. A stereochemical rationale for the reaction is proposed.
Kun Wang et al.
The oncologist, 20(3), 263-269 (2015-02-07)
The TERT promoter and FGFR3 gene mutations are two of the most common genetic events in urothelial bladder cancer (UBC), and these mutation assays in patient urine have been shown to be promising biomarkers for UBC diagnosis and surveillance. These

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持